Sun Pharma buys US-based Organon for $12 billion in biggest-ever overseas pharma deal
India's largest pharma company, Sun Pharma, has made its biggest overseas acquisition, buying Organon & Co for $11.8 billion. This deal significantly expands Sun Pharma's global presence and product range. It will double the company's revenue and EBITDA. The acquisition positions Sun Pharma as a major player in women's health and biosimilars. This strategic move strengthens Sun Pharma's position in the global pharmaceutical market.
